|
1
|
Martin ST, Heneghan HM and Winter DC:
Systematic review and meta-analysis of outcomes following
pathological complete response to neoadjuvant chemoradiotherapy for
rectal cancer. Br J Surg. 99:918–928. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rödel C, Liersch T, Becker H, Fietkau R,
Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M,
Raab HR, et al: Preoperative chemoradiotherapy and postoperative
chemotherapy with fluorouracil and oxaliplatin versus fluorouracil
alone in locally advanced rectal cancer: Initial results of the
German CAO/ARO/AIO-04 randomised phase 3 trial trial. Lancet Oncol.
13:679–687. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Albert JM, Kim KW, Cao C and Lu B:
Targeting the Akt/mammalian target of rapamycin pathway for
radiosensitization of breast cancer. Mol Cancer Ther. 5:1183–1189.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen H, Ma Z, Vanderwaal RP, Feng Z,
Gonzalez-Suarez I, Wang S and Zhang J, Roti Roti JL, Gonzalo S and
Zhang J: The mTOR inhibitor rapamycin suppresses DNA double-strand
break repair. Radiat Res. 175:214–224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Buijsen J, van den Bogaard J, Jutten B,
Belgers E, Sosef M, Leijtens JW, Beets GL, Jansen RL, Riedl RG,
Clarijs R, et al: A phase I–II study on the combination of
rapamycin and short course radiotherapy in rectal cancer. Radiother
Oncol. 116:214–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chaurasia M, Bhatt AN, Das A, Dwarakanath
BS and Sharma K: Radiation-induced autophagy: Mechanisms and
consequences. Free Radic Res. 50:273–290. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu L, Wang H, Huang L, Zhao Y and Wang J:
Crosstalk between autophagy and intracellular radiation response
(Review). Int J Oncol. 49:2217–2226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosich L, Xargay-Torrent S, López-Guerra
M, Campo E, Colomer D and Roué G: Counteracting autophagy overcomes
resistance to everolimus in mantle cell lymphoma. Clin Cancer Res.
18:5278–5289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaneko M, Nozawa H, Hiyoshi M, Tada N,
Murono K, Nirei T, Emoto S, Kishikawa J, Iida Y, Sunami E, et al:
Temsirolimus and chloroquine cooperatively exhibit a potent
antitumor effect against colorectal cancer cells. J Cancer Res Clin
Onco. 140:769–781. 2014. View Article : Google Scholar
|
|
10
|
Mo N, Lu YK, Xie WM, Liu Y, Zhou WX, Wang
HX, Nong L, Jia YX, Tan AH, Chen Y, et al: Inhibition of autophagy
enhances the radiosensitivity of nasopharyngeal carcinoma by
reducing Rad51 expression. Oncol Rep. 32:1905–1912. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Q, Liu T, Yuan Y, Guo Z, Xie G, Du S,
Lin X, Xu Z, Liu M, Wang W, et al: MiR-200c inhibits autophagy and
enhances radiosensitivity in breast cancer cells by targeting
UBQLN1. Int J Cancer. 136:1003–1012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Apel A, Herr I, Schwarz H, Rodemann HP and
Mayer A: Blocked autophagy sensitizes resistant carcinoma cells to
radiation therapy. Cancer Res. 68:1485–1494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okuno T, Kawai K, Hata K, Murono K, Emoto
S, Kaneko M, Sasaki K, Nishikawa T, Tanaka T and Nozawa H: SN-38
Acts as a radiosensitizer for colorectal cancer by inhibiting the
radiation-induced Up-regulation of HIF-1α. Anticancer Res.
38:3323–3331. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saxton RA and Sabatini DM: mTOR signaling
in growth, metabolism, and disease. Cell. 168:960–976. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fingar DC, Richardson CJ, Tee AR, Cheatham
L, Tsou C and Blenis J: mTOR controls cell cycle progression
through its cell growth effectors S6K1 and 4E-BP1/eukaryotic
translation initiation factor 4E. Mol Cell Biol. 24:200–216. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miyasaka A, Oda K, Ikeda Y, Sone K, Fukuda
T, Inaba K, Makii C, Enomoto A, Hosoya N, Tanikawa M, et al:
PI3K/mTOR pathway inhibition overcomes radioresistance via
suppression of the HIF1-α/VEGF pathway in endometrial cancer.
Gynecol Oncol. 138:174–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Edwards E, Geng L, Tan J, Onishko H,
Donnelly E and Hallahan DE: Phosphatidylinositol 3-kinase/Akt
signaling in the response of vascular endothelium to ionizing
radiation. Cancer Res. 62:4671–4677. 2002.PubMed/NCBI
|
|
18
|
Nishikawa T, Tsuno NH, Okaji Y, Shuno Y,
Sasaki K, Hongo K, Sunami E, Kitayama J, Takahashi K and Nagawa H:
Inhibition of autophagy potentiates sulforaphane-induced apoptosis
in human colon cancer cells. Ann Surg Oncol. 17:592–602. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sasaki K, Tsuno NH, Sunami E, Tsurita G,
Kawai K, Okaji Y, Nishikawa T, Shuno Y, Hongo K, Hiyoshi M, et al:
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on
colon cancer cells. BMC Cancer. 10:3702010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Al-Bari MA: Chloroquine analogues in drug
discovery: New directions of uses, mechanisms of actions and toxic
manifestations from malaria to multifarious diseases. J Antimicrob
Chemother. 70:1608–1621. 2015.PubMed/NCBI
|
|
21
|
Cao C, Subhawong T, Albert JM, Kim KW,
Geng L, Sekhar KR, Gi YJ and Lu B: Inhibition of mammalian target
of rapamycin or apoptotic pathway induces autophagy and
radiosensitizes PTEN nulll prostate cancer cells. Cancer Res.
66:10040–10047. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Manegold PC, Paringer C, Kulka U, Krimmel
K, Eichhorn ME, Wilkowski R, Jauch KW, Guba M and Bruns CJ:
Antiangiogenic therapy with mammalian target of rapamycin inhibitor
RAD001 (Everolimus) increases radiosensitivity in solid cancer.
Clin Cancer Res. 14:892–900. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lomonaco SL, Finniss S, Xiang C,
Decarvalho A, Umansky F, Kalkanis SN, Mikkelsen T and Brodie C: The
induction of autophagy by gamma-radiation contributes to the
radioresistance of glioma stem cells. Int J Cancer. 125:717–722.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan C, Luo L, Goto S, Urata Y, Guo CY, Doi
H, Kitazato K and Li TS: Enhanced autophagy in colorectal cancer
stem cells does not contribute to radio-resistance. Oncotarget.
7:45112–45121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bristol ML, Emery SM, Maycotte P, Thorburn
A, Chakradeo S and Gewirtz DA: Autophagy inhibition for
chemosensitization and radiosensitization in cancer: Do the
preclinical data support this therapeutic strategy? J Pharmacol Exp
Ther. 344:544–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Enzenmuller S, Gonzalez P, Debatin KM and
Fulda S: Chloroquine overcomes resistance of lung carcinoma cells
to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated
apoptosis. Anticancer Drugs. 24:14–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seitz C, Hugle M, Cristofanon S,
Tchoghandjian A and Fulda S: The dual PI3K/mTOR inhibitor
NVP-BEZ235 and chloroquine synergize to trigger apoptosis via
mitochondrial-lysosomal cross-talk. Int J Cancer. 132:2682–2693.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choo AY, Yoon SO, Kim SG, Roux PP and
Blenis J: Rapamycin differentially inhibits S6Ks and 4E-BP1 to
mediate cell-type-specific repression of mRNA translation. Proc
Natl Acad Sci USA. 105:17414–17419. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi TT, Yu XX, Yan LJ and Xiao HT:
Research progress of hydroxychloroquine and autophagy inhibitors on
cancer. Cancer Chemother Pharmacol. 79:287–294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Boya P, Gonzalez-Polo RA, Poncet D,
Andreau K, Vieira HL, Roumier T, Perfettini JL and Kroemer G:
Mitochondrial membrane permeabilization is a critical step of
lysosome-initiated apoptosis induced by hydroxychloroquine.
Oncogene. 22:3927–3936. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lakhter AJ, Sahu RP, Sun Y, Kaufmann WK,
Androphy EJ, Travers JB and Naidu SR: Chloroquine promotes
apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA
degradation. J Invest Dermatol. 133:2247–2254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rangwala R, Chang YC, Hu J, Algazy KM,
Evans TL, Fecher LA, Schuchter LM, Torigian DA, Panosian JT, Troxel
AB, et al: Combined MTOR and autophagy inhibition: Phase I trial of
hydroxychloroquine and temsirolimus in patients with advanced solid
tumors and melanoma. Autophagy. 10:1391–1402. 2014. View Article : Google Scholar : PubMed/NCBI
|
